2023 Journal Article Exploring the impact of severity in hepatic fibrosis disease on the intrahepatic distribution of novel biodegradable nanoparticles targeted towards different disease biomarkersBalaji, Arunpandian, Bell, Craig A., Houston, Zachary H., Bridle, Kim R., Genz, Berit, Fletcher, Nicholas L., Ramm, Grant A. and Thurecht, Kristofer J. (2023). Exploring the impact of severity in hepatic fibrosis disease on the intrahepatic distribution of novel biodegradable nanoparticles targeted towards different disease biomarkers. Biomaterials, 302 122318, 1-18. doi: 10.1016/j.biomaterials.2023.122318 |
2023 Journal Article A salivary biomarker panel to detect liver cirrhosisTrevisan França de Lima, Lucas, Crawford, Darrell H. G., Broszczak, Daniel A., Zhang, Xi, Bridle, Kim R. and Punyadeera, Chamindie (2023). A salivary biomarker panel to detect liver cirrhosis. iScience, 26 (7) 107015, 107015. doi: 10.1016/j.isci.2023.107015 |
2023 Conference Publication Reactive oxygen species-mediated hepatic stellate cell activation via PI3K in liver cancerRuan, Qi, Cao, Lu, Yang, Haotian, Burke, Leslie, Bridle, Kim, Crawford, Darrell and Liang, Xiaowen (2023). Reactive oxygen species-mediated hepatic stellate cell activation via PI3K in liver cancer. EASL Congress 2023, Vienna, Austria, 21 - 24 June 2023. Amsterdam, Netherlands: Elsevier. |
2023 Journal Article Clinical practice guidelines on hemochromatosis: Asian Pacific Association for the Study of the LiverCrawford, Darrell H. G., Ramm, Grant A., Bridle, Kim R., Nicoll, Amanda J., Delatycki, Martin B. and Olynyk, John K. (2023). Clinical practice guidelines on hemochromatosis: Asian Pacific Association for the Study of the Liver. Hepatology International, 17 (3), 522-541. doi: 10.1007/s12072-023-10510-3 |
2022 Journal Article Efficacy and safety of immune-modulating therapy for primary sclerosing cholangitis: a systematic review and meta-analysisLiu, Xin, Wang, Haolu, Liu, Xinyao, Bridle, Kim, Crawford, Darrell and Liang, Xiaowen (2022). Efficacy and safety of immune-modulating therapy for primary sclerosing cholangitis: a systematic review and meta-analysis. Pharmacology and Therapeutics, 237 108163, 1-13. doi: 10.1016/j.pharmthera.2022.108163 |
2022 Journal Article Long-term survival and postoperative complications of pre-liver transplantation transarterial chemoembolisation in hepatocellular carcinoma: a systematic review and meta-analysisButcher, Daniel A., Brandis, Kelli J., Wang, Haolu, Spannenburg, Liam, Bridle, Kim R., Crawford, Darrell HG. and Liang, Xiaowen (2022). Long-term survival and postoperative complications of pre-liver transplantation transarterial chemoembolisation in hepatocellular carcinoma: a systematic review and meta-analysis. European Journal of Surgical Oncology, 48 (3), 621-631. doi: 10.1016/j.ejso.2021.09.017 |
2022 Journal Article CD73 and PD-L1 as potential therapeutic targets in gallbladder cancerCao, Lu, Bridle, Kim R., Shrestha, Ritu, Prithviraj, Prashanth, Crawford, Darrell H. G. and Jayachandran, Aparna (2022). CD73 and PD-L1 as potential therapeutic targets in gallbladder cancer. International Journal of Molecular Sciences, 23 (3) 1565, 1565. doi: 10.3390/ijms23031565 |
2021 Journal Article Iron depletion attenuates steatosis in a mouse model of non-alcoholic fatty liver disease: Role of iron-dependent pathwaysCrawford, Darrell H.G., Ross, Diana G.F., Jaskowski, Lesley-Anne, Burke, Leslie J., Britton, Laurence J., Musgrave, Nick, Briskey, David, Rishi, Gautam, Bridle, Kim R. and Subramaniam, V. Nathan (2021). Iron depletion attenuates steatosis in a mouse model of non-alcoholic fatty liver disease: Role of iron-dependent pathways. Biochimica et Biophysica Acta - Molecular Basis of Disease, 1867 (7) 166142, 166142. doi: 10.1016/j.bbadis.2021.166142 |
2021 Journal Article Self-reported liver disorders in Australian Vietnam War veteransWang, H., Liang, X., Bridle, K. and Crawford, D. (2021). Self-reported liver disorders in Australian Vietnam War veterans. Journal of Military and Veterans Health, 29 (3), 43-51. |
2021 Journal Article Dual targeting of sorafenib-resistant HCC-derived cancer stem cellsShrestha, Ritu, Bridle, Kim R., Cao, Lu, Crawford, Darrell H. G. and Jayachandran, Aparna (2021). Dual targeting of sorafenib-resistant HCC-derived cancer stem cells. Current Oncology, 28 (3), 2150-2172. doi: 10.3390/curroncol28030200 |
2021 Journal Article Prognostic role of immune checkpoint regulators in cholangiocarcinoma: a pilot studyCao, Lu, Prithviraj, Prashanth, Shrestha, Ritu, Sharma, Revati, Anaka, Matthew, Bridle, Kim R., Kannourakis, George, Crawford, Darrell H.G. and Jayachandran, Aparna (2021). Prognostic role of immune checkpoint regulators in cholangiocarcinoma: a pilot study. Journal of Clinical Medicine, 10 (10) 2191, 2191. doi: 10.3390/jcm10102191 |
2021 Journal Article Combined inhibition of TGF-β1-induced EMT and PD-L1 silencing re-sensitizes hepatocellular carcinoma to sorafenib treatmentShrestha, Ritu, Prithviraj, Prashanth, Bridle, Kim R., Crawford, Darrell H. G. and Jayachandran, Aparna (2021). Combined inhibition of TGF-β1-induced EMT and PD-L1 silencing re-sensitizes hepatocellular carcinoma to sorafenib treatment. Journal of Clinical Medicine, 10 (9) 1889, 1889. doi: 10.3390/jcm10091889 |
2021 Journal Article Inhibition of MLKL attenuates necroptotic cell death in a murine cell model of ischaemia injuryBaidya, Raji, Gautheron, Jérémie, Crawford, Darrell H. G., Wang, Haolu and Bridle, Kim R. (2021). Inhibition of MLKL attenuates necroptotic cell death in a murine cell model of ischaemia injury. Journal of Clinical Medicine, 10 (2) 212, 1-18. doi: 10.3390/jcm10020212 |
2021 Journal Article Immune checkpoint molecules are regulated by transforming growth factor (Tgf)-β1-induced epithelial-to-mesenchymal transition in hepatocellular carcinomaShrestha, Ritu, Bridle, Kim R., Crawford, Darrell H. G. and Jayachandran, Aparna (2021). Immune checkpoint molecules are regulated by transforming growth factor (Tgf)-β1-induced epithelial-to-mesenchymal transition in hepatocellular carcinoma. International Journal of Medical Sciences, 18 (12), 2466-2479. doi: 10.7150/ijms.54239 |
2020 Journal Article Assessment and transplantation of orphan donor livers: a back-to-base approach to normothermic machine perfusionReiling, Janske, Butler, Nick, Simpson, Andrew, Hodgkinson, Peter, Campbell, Catherine, Lockwood, David, Bridle, Kim, Santrampurwala, Nishreen, Britton, Laurence, Crawford, Darrell, Dejong, Cornelius H. C. and Fawcett, Jonathan (2020). Assessment and transplantation of orphan donor livers: a back-to-base approach to normothermic machine perfusion. Liver Transplantation, 26 (12), 1618-1628. doi: 10.1002/lt.25850 |
2020 Journal Article The use of minimally invasive biomarkers for the diagnosis and prognosis of hepatocellular carcinomaTrevisan França de Lima, Lucas, Broszczak, Daniel, Zhang, Xi, Bridle, Kim, Crawford, Darrell and Punyadeera, Chamindie (2020). The use of minimally invasive biomarkers for the diagnosis and prognosis of hepatocellular carcinoma. Biochimica et Biophysica Acta - Reviews on Cancer, 1874 (2) 188451, 188451. doi: 10.1016/j.bbcan.2020.188451 |
2020 Journal Article Necroptosis in hepatosteatotic ischaemia-reperfusion injuryBaidya, Raji, Crawford, Darrell H. G., Gautheron, Jérémie, Wang, Haolu and Bridle, Kim R. (2020). Necroptosis in hepatosteatotic ischaemia-reperfusion injury. International Journal of Molecular Sciences, 21 (16) 5931, 1-29. doi: 10.3390/ijms21165931 |
2020 Journal Article TNF-α-mediated epithelial-to-mesenchymal transition regulates expression of immune checkpoint molecules in hepatocellular carcinomaShrestha, Ritu, Bridle, Kim R., Crawford, Darrell H.G. and Jayachandran, Aparna (2020). TNF-α-mediated epithelial-to-mesenchymal transition regulates expression of immune checkpoint molecules in hepatocellular carcinoma. Molecular Medicine Reports, 21 (4), 1849-1860. doi: 10.3892/mmr.2020.10991 |
2020 Journal Article Association between hereditary hemochromatosis and hepatocellular carcinoma: a comprehensive reviewJayachandran, Aparna, Shrestha, Ritu, Bridle, Kim R. and Crawford, Darrell H. G. (2020). Association between hereditary hemochromatosis and hepatocellular carcinoma: a comprehensive review. Hepatoma Research, 6 8. doi: 10.20517/2394-5079.2019.35 |
2020 Journal Article Therapeutic modulators of hepatic stellate cells for hepatocellular carcinomaRuan, Qi, Wang, Haolu, Burke, Leslie J., Bridle, Kim R., Li, Xinxing, Zhao, Chun-Xia, Crawford, Darrell H. G., Roberts, Michael S. and Liang, Xiaowen (2020). Therapeutic modulators of hepatic stellate cells for hepatocellular carcinoma. International Journal of Cancer, 147 (6) ijc.32899, 1519-1527. doi: 10.1002/ijc.32899 |